Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

FP7

NeoStrep

Project ID: 601743
Finanziato nell'ambito di

Development of Group B Streptococcal vaccine to alleviate emerging antibiotic resistance through elimination of current prophylactic antibiotic strategies in GBS prevention

Dal 2013-07-01 al 2016-06-30, progetto concluso | NeoStrep Sito web

Dettagli del progetto

Costo totale:

EUR 7 969 300

Contributo UE:

EUR 5 999 172

Coordinato in:

Sweden

Invito a presentare proposte:

FP7-HEALTH-2013-INNOVATION-2See other projects for this call

Meccanismo di finanziamento:

CP-FP - Small or medium-scale focused research project

Obiettivo

Coordinatore

LUNDS UNIVERSITET
Sweden

Contributo UE: EUR 1 050 734,50


Paradisgatan 5c
22100 LUND
Sweden
Activity type: Higher or Secondary Education Establishments
Contatto amministrativo: Stina Ahlenius
Tel.: +46 46173465
Fax: +46 46130064
E-mail

Partecipanti

MINERVAX APS
Denmark

Contributo UE: EUR 3 124 600


VEDBENDVEJ 28
2900 HELLERUP
Denmark
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Per Fischer
Tel.: +45 20252038
E-mail
BIO-KINETIC EUROPE LIMITED
Ireland

Contributo UE: EUR 1 624 077


GREAT VICTORIA STREET 14
BT2 7BA BELFAST
Ireland
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Crawford Maclean
Tel.: +44 2890818381
Fax: +44 2890238123
E-mail
CITOXLAB SCANTOX AS
Denmark

Contributo UE: EUR 199 760,50


Hestehavevej 36A
4623 Lille Skensved
Denmark
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Andrew Makin
Tel.: +45 56 86 15 26
Fax: +45 56 92 12 02
E-mail

Argomenti

Life Sciences
Numero di registrazione: 108885 / Ultimo aggiornamento: 2016-03-31